格洛布斯醫療有限公司
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionHolocene Advisors, LP
Latest Disclosed Ownership773,834 shares
Latest Disclosed Value $ 66,673,537
Holocene Advisors, LP ownership in GMED / Globus Medical, Inc.

On May 15, 2026 - Holocene Advisors, LP filed a 13F-HR form disclosing ownership of 773,834 shares of Globus Medical, Inc. (MX:GMED) valued at $66,673,537 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of Globus Medical, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GLOBUS MED CL A 379577208 773,834 773,834 66,674 0.1608
2025-08-14 2025-06-30 13F GLOBUS MED CL A 379577208 0 -460,087 -100.00 0 -100.00
2025-05-15 2025-03-31 13F GLOBUS MED CL A 379577208 460,087 460,087 33,678 0.0983
2024-05-15 2024-03-31 13F GLOBUS MED CL A 379577208 0 -137,193 -100.00 0 -100.00
2024-02-14 2023-12-31 13F GLOBUS MED CL A 379577208 137,193 53,637 64.19 7,311 76.25 0.0285
2023-11-14 2023-09-30 13F GLOBUS MED CL A 379577208 83,556 -47,901 -36.44 4,149 -47.00 0.0182
2023-08-14 2023-06-30 13F GLOBUS MED CL A 379577208 131,457 115,590 728.49 7,827 771.49 0.0334
2023-05-15 2023-03-31 13F GLOBUS MED CL A 379577208 15,867 15,867 899 0.0044
2021-08-16 2021-06-30 13F GLOBUS MED CL A 379577208 0 -10,691 -100.00 0 -100.00
2021-05-17 2021-03-31 13F GLOBUS MED CL A 379577208 10,691 2,945 38.02 659 30.50 0.0041
2021-02-16 2020-12-31 13F GLOBUS MED CL A 379577208 7,746 7,746 505 0.0032
2020-05-15 2020-03-31 13F GLOBUS MED CL A 379577208 0 -32,659 -100.00 0 -100.00
2020-02-14 2019-12-31 13F GLOBUS MED CL A 379577208 32,659 15,006 85.01 1,923 113.19 0.0172
2019-11-14 2019-09-30 13F GLOBUS MED CL A 379577208 17,653 17,653 902 0.0093
2019-08-14 2019-06-30 13F GLOBUS MED CL A 379577208 0 -5,433 -100.00 0 -100.00
2019-05-15 2019-03-31 13F GLOBUS MED CL A 379577208 5,433 5,433 268 0.0041
2019-02-14 2018-12-31 13F GLOBUS MED CL A 379577208 0 -7,659 -100.00 0 -100.00
2018-11-14 2018-09-30 13F GLOBUS MED CL A 379577208 7,659 7,659 435 0.0070
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.